Global Pharmacogenomics Market By Technology (Sequencing, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, Microarray and Others), By Application (Oncology, Psychiatry, Infectious Diseases, Neurological Diseases, Pain management, Cardiovascular Diseases and Others), By End User (Hospitals and Clinics, Research Institutions, and Academic Institutes)

The Global Pharmacogenomics Market size is expected to reach $9.9 billion by 2025, rising at a market growth of 8.8% CAGR during the forecast period.

Pharmacogenomics or personalized medicine is defined as ?the tailoring of medical treatment to the specific characteristics of each patient.? This concept, in reality, involves the ability to classify individuals into sub-populations which are disproportionately susceptible to a particular disease or responsive to a particular treatment. Personalized medicine emphasizes on the paradigm shift in medicine from reaction to prevention. The individual response to the drug varies according to the genetic composition. Most of the responses are positive and show improvement while few face the side effects. To address those variations, it is necessary to study how the drug processing is affected by the genes. So when the genetic variation is affecting the drug processing and response, there is the scope of the clinical study to be conducted and based on the result, adjust the dosage or to find a different drug according to the genetic composition of an individual.

Global Pharmacogenomics Market Size

Increase in the geriatric population, growing adoption of pharmacogenomics procedure by healthcare professionals, increased awareness of patients towards personalized therapy, and the emerging prevalence of chronic diseases like cancer, tuberculosis, HIV, and others, are driving the growth of pharmacogenomics market.

Click Here For Free Insights

Based on Technology, the market is segmented into Sequencing, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, Microarray and Others. Based on Application, the market is segmented into Oncology, Psychiatry, Infectious Diseases, Neurological Diseases, Pain management, Cardiovascular Diseases and Others. Based on End User, the market is segmented into Hospitals and Clinics, Research Institutions, and Academic Institutes. The hospitals and clinics segment accounted for the largest share among end users for pharmacogenomic products, followed by research organizations and academic institutes. This is attributed to the fact that hospitals are well-equipped with molecular diagnostic lab units to cater to the different needs of the patients. Moreover, pharmacogenomics lab units at hospitals are well-equipped with highly superior systems. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

Global Pharmacogenomics Market Share

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Empire Genomics LLC, Illumina, Inc., oneome LLC, Myriad Genetics Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Opko Health, Inc., and Becton, Dickinson and Company.

Scope of the Pharmacogenomics Market Analysis

Market Segmentation:

By Technology

• Sequencing
• Polymerase Chain Reaction
• Electrophoresis
• Mass Spectrometry
• Microarray
• Others

By Application

• Oncology
• Psychiatry
• Infectious Diseases
• Neurological Diseases
• Pain management
• Cardiovascular Diseases
• Others

By End User

• Hospitals and Clinics
• Research Institutions
• Academic Institutes

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Abbott Laboratories
• Empire Genomics LLC
• Illumina, Inc.
• OneOme LLC
• Myriad Genetics Inc.
• Thermo Fisher Scientific, Inc.
• Teva Pharmaceuticals Industries Ltd.
• Bayer AG
• Opko Health, Inc.
• Becton, Dickinson and Company

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Pharmacogenomics Market, by Application
1.4.2 Global Pharmacogenomics Market, by Application
1.4.3 Global Pharmacogenomics Market, by End User
1.4.4 Global Pharmacogenomics Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Pharmacogenomics Market by Technology
3.1.1 Global Sequencing Market by Region
3.1.2 Global Polymerase Chain Reaction Market by Region
3.1.3 Global Electrophoresis Market by Region
3.1.4 Global Mass Spectrometry Market by Region
3.1.5 Global Microarray Market by Region
3.1.6 Global Others Market by Region
Chapter 4. Global Pharmacogenomics Market by Application
4.1.1 Global Oncology Market by Region
4.1.2 Global Psychiatry Market by Region
4.1.3 Global Infectious Diseases Market by Region
4.1.4 Global Neurological Diseases Market by Region
4.1.5 Global Pain Management Market by Region
4.1.6 Global Cardiovascular Diseases Market by Region
4.1.7 Global Others Market by Region
Chapter 5. Global Pharmacogenomics Market by End User
5.1.1 Global Hospitals and Clinics Market by Region
5.1.2 Global Research Institutions Market by Region
5.1.3 Global Academic Institutes Market by Region
Chapter 6. Global Pharmacogenomics Market by Region
6.1 North America Pharmacogenomics Market
6.1.1 North America Pharmacogenomics Market by Technology
6.1.1.1 North America Sequencing Market by Country
6.1.1.2 North America Polymerase Chain Reaction Market by Country
6.1.1.3 North America Electrophoresis Market by Country
6.1.1.4 North America Mass Spectrometry Market by Country
6.1.1.5 North America Microarray Market by Country
6.1.1.6 North America Others Market by Country
6.1.2 North America Pharmacogenomics Market by Application
6.1.2.1 North America Oncology Market by Country
6.1.2.2 North America Psychiatry Market by Country
6.1.2.3 North America Infectious Diseases Market by Country
6.1.2.4 North America Neurological Diseases Market by Country
6.1.2.5 North America Pain Management Market by Country
6.1.2.6 North America Cardiovascular Diseases Market by Country
6.1.2.7 North America Others Market by Country
6.1.3 North America Pharmacogenomics Market by End User
6.1.3.1 North America Hospitals and Clinics Market by Country
6.1.3.2 North America Research Institutions Market by Country
6.1.3.3 North America Academic Institutes Market by Country
6.1.4 North America Pharmacogenomics Market by Country
6.1.4.1 USA Pharmacogenomics Market
6.1.4.1.1 USA Pharmacogenomics Market by Technology
6.1.4.1.2 USA Pharmacogenomics Market by Application
6.1.4.1.3 USA Pharmacogenomics Market by End User
6.1.4.2 Canada Pharmacogenomics Market
6.1.4.2.1 Canada Pharmacogenomics Market by Technology
6.1.4.2.2 Canada Pharmacogenomics Market by Application
6.1.4.2.3 Canada Pharmacogenomics Market by End User
6.1.4.3 Mexico Pharmacogenomics Market
6.1.4.3.1 Mexico Pharmacogenomics Market by Technology
6.1.4.3.2 Mexico Pharmacogenomics Market by Application
6.1.4.3.3 Mexico Pharmacogenomics Market by End User
6.1.4.4 Rest of North America Pharmacogenomics Market
6.1.4.4.1 Rest of North America Pharmacogenomics Market by Technology
6.1.4.4.2 Rest of North America Pharmacogenomics Market by Application
6.1.4.4.3 Rest of North America Pharmacogenomics Market by End User
6.2 Europe Pharmacogenomics Market
6.2.1 Europe Pharmacogenomics Market by Technology
6.2.1.1 Europe Sequencing Market by Country
6.2.1.2 Europe Polymerase Chain Reaction Market by Country
6.2.1.3 Europe Electrophoresis Market by Country
6.2.1.4 Europe Mass Spectrometry Market by Country
6.2.1.5 Europe Microarray Market by Country
6.2.1.6 Europe Others Market by Country
6.2.2 Europe Pharmacogenomics Market by Application
6.2.2.1 Europe Oncology Market by Country
6.2.2.2 Europe Psychiatry Market by Country
6.2.2.3 Europe Infectious Diseases Market by Country
6.2.2.4 Europe Neurological Diseases Market by Country
6.2.2.5 Europe Pain Management Market by Country
6.2.2.6 Europe Cardiovascular Diseases Market by Country
6.2.2.7 Europe Others Market by Country
6.2.3 Europe Pharmacogenomics Market by End User
6.2.3.1 Europe Hospitals and Clinics Market by Country
6.2.3.2 Europe Research Institutions Market by Country
6.2.3.3 Europe Academic Institutes Market by Country
6.2.4 Europe Pharmacogenomics Market by Country
6.2.4.1 Germany Pharmacogenomics Market
6.2.4.1.1 Germany Pharmacogenomics Market by Technology
6.2.4.1.2 Germany Pharmacogenomics Market by Application
6.2.4.1.3 Germany Pharmacogenomics Market by End User
6.2.4.2 UK Pharmacogenomics Market
6.2.4.2.1 UK Pharmacogenomics Market by Technology
6.2.4.2.2 UK Pharmacogenomics Market by Application
6.2.4.2.3 UK Pharmacogenomics Market by End User
6.2.4.3 France Pharmacogenomics Market
6.2.4.3.1 France Pharmacogenomics Market by Technology
6.2.4.3.2 France Pharmacogenomics Market by Application
6.2.4.3.3 France Pharmacogenomics Market by End User
6.2.4.4 Russia Pharmacogenomics Market
6.2.4.4.1 Russia Pharmacogenomics Market by Technology
6.2.4.4.2 Russia Pharmacogenomics Market by Application
6.2.4.4.3 Russia Pharmacogenomics Market by End User
6.2.4.5 Spain Pharmacogenomics Market
6.2.4.5.1 Spain Pharmacogenomics Market by Technology
6.2.4.5.2 Spain Pharmacogenomics Market by Application
6.2.4.5.3 Spain Pharmacogenomics Market by End User
6.2.4.6 Italy Pharmacogenomics Market
6.2.4.6.1 Italy Pharmacogenomics Market by Technology
6.2.4.6.2 Italy Pharmacogenomics Market by Application
6.2.4.6.3 Italy Pharmacogenomics Market by End User
6.2.4.7 Rest of Europe Pharmacogenomics Market
6.2.4.7.1 Rest of Europe Pharmacogenomics Market by Technology
6.2.4.7.2 Rest of Europe Pharmacogenomics Market by Application
6.2.4.7.3 Rest of Europe Pharmacogenomics Market by End User
6.3 Asia Pacific Pharmacogenomics Market
6.3.1 Asia Pacific Pharmacogenomics Market by Technology
6.3.1.1 Asia Pacific Sequencing Market by Country
6.3.1.2 Asia Pacific Polymerase Chain Reaction Market by Country
6.3.1.3 Asia Pacific Electrophoresis Market by Country
6.3.1.4 Asia Pacific Mass Spectrometry Market by Country
6.3.1.5 Asia Pacific Microarray Market by Country
6.3.1.6 Asia Pacific Others Market by Country
6.3.2 Asia Pacific Pharmacogenomics Market by Application
6.3.2.1 Asia Pacific Oncology Market by Country
6.3.2.2 Asia Pacific Psychiatry Market by Country
6.3.2.3 Asia Pacific Infectious Diseases Market by Country
6.3.2.4 Asia Pacific Neurological Diseases Market by Country
6.3.2.5 Asia Pacific Pain Management Market by Country
6.3.2.6 Asia Pacific Cardiovascular Diseases Market by Country
6.3.2.7 Asia Pacific Others Market by Country
6.3.3 Asia Pacific Pharmacogenomics Market by End User
6.3.3.1 Asia Pacific Hospitals and Clinics Market by Country
6.3.3.2 Asia Pacific Research Institutions Market by Country
6.3.3.3 Asia Pacific Academic Institutes Market by Country
6.3.4 Asia Pacific Pharmacogenomics Market by Country
6.3.4.1 China Pharmacogenomics Market
6.3.4.1.1 China Pharmacogenomics Market by Technology
6.3.4.1.2 China Pharmacogenomics Market by Application
6.3.4.1.3 China Pharmacogenomics Market by End User
6.3.4.2 Japan Pharmacogenomics Market
6.3.4.2.1 Japan Pharmacogenomics Market by Technology
6.3.4.2.2 Japan Pharmacogenomics Market by Application
6.3.4.2.3 Japan Pharmacogenomics Market by End User
6.3.4.3 India Pharmacogenomics Market
6.3.4.3.1 India Pharmacogenomics Market by Technology
6.3.4.3.2 India Pharmacogenomics Market by Application
6.3.4.3.3 India Pharmacogenomics Market by End User
6.3.4.4 South Korea Pharmacogenomics Market
6.3.4.4.1 South Korea Pharmacogenomics Market by Technology
6.3.4.4.2 South Korea Pharmacogenomics Market by Application
6.3.4.4.3 South Korea Pharmacogenomics Market by End User
6.3.4.5 Singapore Pharmacogenomics Market
6.3.4.5.1 Singapore Pharmacogenomics Market by Technology
6.3.4.5.2 Singapore Pharmacogenomics Market by Application
6.3.4.5.3 Singapore Pharmacogenomics Market by End User
6.3.4.6 Malaysia Pharmacogenomics Market
6.3.4.6.1 Malaysia Pharmacogenomics Market by Technology
6.3.4.6.2 Malaysia Pharmacogenomics Market by Application
6.3.4.6.3 Malaysia Pharmacogenomics Market by End User
6.3.4.7 Rest of Asia Pacific Pharmacogenomics Market
6.3.4.7.1 Rest of Asia Pacific Pharmacogenomics Market by Technology
6.3.4.7.2 Rest of Asia Pacific Pharmacogenomics Market by Application
6.3.4.7.3 Rest of Asia Pacific Pharmacogenomics Market by End User
6.4 LAMEA Pharmacogenomics Market
6.4.1 LAMEA Pharmacogenomics Market by Technology
6.4.1.1 LAMEA Sequencing Market by Country
6.4.1.2 LAMEA Polymerase Chain Reaction Market by Country
6.4.1.3 LAMEA Electrophoresis Market by Country
6.4.1.4 LAMEA Mass Spectrometry Market by Country
6.4.1.5 LAMEA Microarray Market by Country
6.4.1.6 LAMEA Others Market by Country
6.4.2 LAMEA Pharmacogenomics Market by Application
6.4.2.1 LAMEA Oncology Market by Country
6.4.2.2 LAMEA Psychiatry Market by Country
6.4.2.3 LAMEA Infectious Diseases Market by Country
6.4.2.4 LAMEA Neurological Diseases Market by Country
6.4.2.5 LAMEA Pain Management Market by Country
6.4.2.6 LAMEA Cardiovascular Diseases Market by Country
6.4.2.7 LAMEA Others Market by Country
6.4.3 LAMEA Pharmacogenomics Market by End User
6.4.3.1 LAMEA Hospitals and Clinics Market by Country
6.4.3.2 LAMEA Research Institutions Market by Country
6.4.3.3 LAMEA Academic Institutes Market by Country
6.4.4 LAMEA Pharmacogenomics Market by Country
6.4.4.1 Brazil Pharmacogenomics Market
6.4.4.1.1 Brazil Pharmacogenomics Market by Technology
6.4.4.1.2 Brazil Pharmacogenomics Market by Application
6.4.4.1.3 Brazil Pharmacogenomics Market by End User
6.4.4.2 Argentina Pharmacogenomics Market
6.4.4.2.1 Argentina Pharmacogenomics Market by Technology
6.4.4.2.2 Argentina Pharmacogenomics Market by Application
6.4.4.2.3 Argentina Pharmacogenomics Market by End User
6.4.4.3 UAE Pharmacogenomics Market
6.4.4.3.1 UAE Pharmacogenomics Market by Technology
6.4.4.3.2 UAE Pharmacogenomics Market by Application
6.4.4.3.3 UAE Pharmacogenomics Market by End User
6.4.4.4 Saudi Arabia Pharmacogenomics Market
6.4.4.4.1 Saudi Arabia Pharmacogenomics Market by Technology
6.4.4.4.2 Saudi Arabia Pharmacogenomics Market by Application
6.4.4.4.3 Saudi Arabia Pharmacogenomics Market by End User
6.4.4.5 South Africa Pharmacogenomics Market
6.4.4.5.1 South Africa Pharmacogenomics Market by Technology
6.4.4.5.2 South Africa Pharmacogenomics Market by Application
6.4.4.5.3 South Africa Pharmacogenomics Market by End User
6.4.4.6 Nigeria Pharmacogenomics Market
6.4.4.6.1 Nigeria Pharmacogenomics Market by Technology
6.4.4.6.2 Nigeria Pharmacogenomics Market by Application
6.4.4.6.3 Nigeria Pharmacogenomics Market by End User
6.4.4.7 Rest of LAMEA Pharmacogenomics Market
6.4.4.7.1 Rest of LAMEA Pharmacogenomics Market by Technology
6.4.4.7.2 Rest of LAMEA Pharmacogenomics Market by Application
6.4.4.7.3 Rest of LAMEA Pharmacogenomics Market by End User
Chapter 7. Company Profiles
7.1 ABBOTT Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Collaborations, partnerships and agreements:
7.1.5.2 Product launches:
7.1.5.3 Acquisition and mergers:
7.1.6 SWOT Analysis
7.2 Empire Genomics LLC
7.2.1 Company Overview
7.3 Illumina, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional& Segmental Analysis
7.3.4 Research& Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Collaborations, partnerships and agreements:
7.3.5.2 Product launches:
7.3.5.3 Acquisition and mergers:
7.4 OneOme LLC
7.4.1 Company Overview
7.5 Myriad Genetics Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Collaborations, partnerships and agreements:
7.5.5.2 Product launches:
7.6 Thermo Fischer Scientific, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Collaborations, partnerships and agreements:
7.6.5.2 Acquisition and mergers:
7.6.6 SWOT Analysis
7.7 Teva Pharmaceuticals Industries Ltd.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Product launches:
7.8 Bayer AG
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.8.6 SWOT Analysis
7.9 Opko Health, Inc. (GeneDx, Inc.)
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Research & Development Expense
7.9.4 Recent strategies and developments:
7.9.4.1 Collaborations, partnerships and agreements:
7.9.4.2 Product launches:
7.1 Becton, Dickinson and Company
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Collaborations, partnerships and agreements:
7.10.5.2 Acquisition and mergers:
7.10.5.3 Product launches:
7.10.6 SWOT Analysis

TABLE 1 Global Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 2 Global Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 3 Global Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 4 Global Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 5 Global Sequencing Market by Region, 2015 - 2018, USD Million
TABLE 6 Global Sequencing Market by Region, 2019 - 2025, USD Million
TABLE 7 Global Polymerase Chain Reaction Market by Region, 2015 - 2018, USD Million
TABLE 8 Global Polymerase Chain Reaction Market by Region, 2019 - 2025, USD Million
TABLE 9 Global Electrophoresis Market by Region, 2015 - 2018, USD Million
TABLE 10 Global Electrophoresis Market by Region, 2019 - 2025, USD Million
TABLE 11 Global Mass Spectrometry Market by Region, 2015 - 2018, USD Million
TABLE 12 Global Mass Spectrometry Market by Region, 2019 - 2025, USD Million
TABLE 13 Global Microarray Market by Region, 2015 - 2018, USD Million
TABLE 14 Global Microarray Market by Region, 2019 - 2025, USD Million
TABLE 15 Global Others Market by Region, 2015 - 2018, USD Million
TABLE 16 Global Others Market by Region, 2019 - 2025, USD Million
TABLE 17 Global Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 18 Global Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 19 Global Oncology Market by Region, 2015 - 2018, USD Million
TABLE 20 Global Oncology Market by Region, 2019 - 2025, USD Million
TABLE 21 Global Psychiatry Market by Region, 2015 - 2018, USD Million
TABLE 22 Global Psychiatry Market by Region, 2019 - 2025, USD Million
TABLE 23 Global Infectious Diseases Market by Region, 2015 - 2018, USD Million
TABLE 24 Global Infectious Diseases Market by Region, 2019 - 2025, USD Million
TABLE 25 Global Neurological Diseases Market by Region, 2015 - 2018, USD Million
TABLE 26 Global Neurological Diseases Market by Region, 2019 - 2025, USD Million
TABLE 27 Global Pain Management Market by Region, 2015 - 2018, USD Million
TABLE 28 Global Pain Management Market by Region, 2019 - 2025, USD Million
TABLE 29 Global Cardiovascular Diseases Market by Region, 2015 - 2018, USD Million
TABLE 30 Global Cardiovascular Diseases Market by Region, 2019 - 2025, USD Million
TABLE 31 Global Others Market by Region, 2015 - 2018, USD Million
TABLE 32 Global Others Market by Region, 2019 - 2025, USD Million
TABLE 33 Global Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 34 Global Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 35 Global Hospitals and Clinics Market by Region, 2015 - 2018, USD Million
TABLE 36 Global Hospitals and Clinics Market by Region, 2019 - 2025, USD Million
TABLE 37 Global Research Institutions Market by Region, 2015 - 2018, USD Million
TABLE 38 Global Research Institutions Market by Region, 2019 - 2025, USD Million
TABLE 39 Global Academic Institutes Market by Region, 2015 - 2018, USD Million
TABLE 40 Global Academic Institutes Market by Region, 2019 - 2025, USD Million
TABLE 41 Global Pharmacogenomics Market by Region, 2015 - 2018, USD Million
TABLE 42 Global Pharmacogenomics Market by Region, 2019 - 2025, USD Million
TABLE 43 North America Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 44 North America Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 45 North America Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 46 North America Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 47 North America Sequencing Market by Country, 2015 - 2018, USD Million
TABLE 48 North America Sequencing Market by Country, 2019 - 2025, USD Million
TABLE 49 North America Polymerase Chain Reaction Market by Country, 2015 - 2018, USD Million
TABLE 50 North America Polymerase Chain Reaction Market by Country, 2019 - 2025, USD Million
TABLE 51 North America Electrophoresis Market by Country, 2015 - 2018, USD Million
TABLE 52 North America Electrophoresis Market by Country, 2019 - 2025, USD Million
TABLE 53 North America Mass Spectrometry Market by Country, 2015 - 2018, USD Million
TABLE 54 North America Mass Spectrometry Market by Country, 2019 - 2025, USD Million
TABLE 55 North America Microarray Market by Country, 2015 - 2018, USD Million
TABLE 56 North America Microarray Market by Country, 2019 - 2025, USD Million
TABLE 57 North America Others Market by Country, 2015 - 2018, USD Million
TABLE 58 North America Others Market by Country, 2019 - 2025, USD Million
TABLE 59 North America Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 60 North America Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 61 North America Oncology Market by Country, 2015 - 2018, USD Million
TABLE 62 North America Oncology Market by Country, 2019 - 2025, USD Million
TABLE 63 North America Psychiatry Market by Country, 2015 - 2018, USD Million
TABLE 64 North America Psychiatry Market by Country, 2019 - 2025, USD Million
TABLE 65 North America Infectious Diseases Market by Country, 2015 - 2018, USD Million
TABLE 66 North America Infectious Diseases Market by Country, 2019 - 2025, USD Million
TABLE 67 North America Neurological Diseases Market by Country, 2015 - 2018, USD Million
TABLE 68 North America Neurological Diseases Market by Country, 2019 - 2025, USD Million
TABLE 69 North America Pain Management Market by Country, 2015 - 2018, USD Million
TABLE 70 North America Pain Management Market by Country, 2019 - 2025, USD Million
TABLE 71 North America Cardiovascular Diseases Market by Country, 2015 - 2018, USD Million
TABLE 72 North America Cardiovascular Diseases Market by Country, 2019 - 2025, USD Million
TABLE 73 North America Others Market by Country, 2015 - 2018, USD Million
TABLE 74 North America Others Market by Country, 2019 - 2025, USD Million
TABLE 75 North America Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 76 North America Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 77 North America Hospitals and Clinics Market by Country, 2015 - 2018, USD Million
TABLE 78 North America Hospitals and Clinics Market by Country, 2019 - 2025, USD Million
TABLE 79 North America Research Institutions Market by Country, 2015 - 2018, USD Million
TABLE 80 North America Research Institutions Market by Country, 2019 - 2025, USD Million
TABLE 81 North America Academic Institutes Market by Country, 2015 - 2018, USD Million
TABLE 82 North America Academic Institutes Market by Country, 2019 - 2025, USD Million
TABLE 83 North America Pharmacogenomics Market by Country, 2015 - 2018, USD Million
TABLE 84 North America Pharmacogenomics Market by Country, 2019 - 2025, USD Million
TABLE 85 USA Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 86 USA Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 87 USA Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 88 USA Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 89 USA Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 90 USA Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 91 USA Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 92 USA Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 93 Canada Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 94 Canada Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 95 Canada Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 96 Canada Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 97 Canada Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 98 Canada Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 99 Canada Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 100 Canada Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 101 Mexico Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 102 Mexico Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 103 Mexico Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 104 Mexico Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 105 Mexico Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 106 Mexico Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 107 Mexico Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 108 Mexico Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 109 Rest of North America Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 110 Rest of North America Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 111 Rest of North America Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 112 Rest of North America Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 113 Rest of North America Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 114 Rest of North America Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 115 Rest of North America Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 116 Rest of North America Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 117 Europe Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 118 Europe Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 119 Europe Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 120 Europe Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 121 Europe Sequencing Market by Country, 2015 - 2018, USD Million
TABLE 122 Europe Sequencing Market by Country, 2019 - 2025, USD Million
TABLE 123 Europe Polymerase Chain Reaction Market by Country, 2015 - 2018, USD Million
TABLE 124 Europe Polymerase Chain Reaction Market by Country, 2019 - 2025, USD Million
TABLE 125 Europe Electrophoresis Market by Country, 2015 - 2018, USD Million
TABLE 126 Europe Electrophoresis Market by Country, 2019 - 2025, USD Million
TABLE 127 Europe Mass Spectrometry Market by Country, 2015 - 2018, USD Million
TABLE 128 Europe Mass Spectrometry Market by Country, 2019 - 2025, USD Million
TABLE 129 Europe Microarray Market by Country, 2015 - 2018, USD Million
TABLE 130 Europe Microarray Market by Country, 2019 - 2025, USD Million
TABLE 131 Europe Others Market by Country, 2015 - 2018, USD Million
TABLE 132 Europe Others Market by Country, 2019 - 2025, USD Million
TABLE 133 Europe Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 134 Europe Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 135 Europe Oncology Market by Country, 2015 - 2018, USD Million
TABLE 136 Europe Oncology Market by Country, 2019 - 2025, USD Million
TABLE 137 Europe Psychiatry Market by Country, 2015 - 2018, USD Million
TABLE 138 Europe Psychiatry Market by Country, 2019 - 2025, USD Million
TABLE 139 Europe Infectious Diseases Market by Country, 2015 - 2018, USD Million
TABLE 140 Europe Infectious Diseases Market by Country, 2019 - 2025, USD Million
TABLE 141 Europe Neurological Diseases Market by Country, 2015 - 2018, USD Million
TABLE 142 Europe Neurological Diseases Market by Country, 2019 - 2025, USD Million
TABLE 143 Europe Pain Management Market by Country, 2015 - 2018, USD Million
TABLE 144 Europe Pain Management Market by Country, 2019 - 2025, USD Million
TABLE 145 Europe Cardiovascular Diseases Market by Country, 2015 - 2018, USD Million
TABLE 146 Europe Cardiovascular Diseases Market by Country, 2019 - 2025, USD Million
TABLE 147 Europe Others Market by Country, 2015 - 2018, USD Million
TABLE 148 Europe Others Market by Country, 2019 - 2025, USD Million
TABLE 149 Europe Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 150 Europe Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 151 Europe Hospitals and Clinics Market by Country, 2015 - 2018, USD Million
TABLE 152 Europe Hospitals and Clinics Market by Country, 2019 - 2025, USD Million
TABLE 153 Europe Research Institutions Market by Country, 2015 - 2018, USD Million
TABLE 154 Europe Research Institutions Market by Country, 2019 - 2025, USD Million
TABLE 155 Europe Academic Institutes Market by Country, 2015 - 2018, USD Million
TABLE 156 Europe Academic Institutes Market by Country, 2019 - 2025, USD Million
TABLE 157 Europe Pharmacogenomics Market by Country, 2015 - 2018, USD Million
TABLE 158 Europe Pharmacogenomics Market by Country, 2019 - 2025, USD Million
TABLE 159 Germany Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 160 Germany Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 161 Germany Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 162 Germany Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 163 Germany Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 164 Germany Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 165 Germany Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 166 Germany Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 167 UK Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 168 UK Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 169 UK Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 170 UK Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 171 UK Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 172 UK Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 173 UK Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 174 UK Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 175 France Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 176 France Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 177 France Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 178 France Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 179 France Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 180 France Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 181 France Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 182 France Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 183 Russia Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 184 Russia Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 185 Russia Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 186 Russia Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 187 Russia Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 188 Russia Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 189 Russia Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 190 Russia Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 191 Spain Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 192 Spain Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 193 Spain Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 194 Spain Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 195 Spain Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 196 Spain Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 197 Spain Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 198 Spain Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 199 Italy Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 200 Italy Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 201 Italy Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 202 Italy Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 203 Italy Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 204 Italy Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 205 Italy Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 206 Italy Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 207 Rest of Europe Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 208 Rest of Europe Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 209 Rest of Europe Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 210 Rest of Europe Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 211 Rest of Europe Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 212 Rest of Europe Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 213 Rest of Europe Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 214 Rest of Europe Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 215 Asia Pacific Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 216 Asia Pacific Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 217 Asia Pacific Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 218 Asia Pacific Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 219 Asia Pacific Sequencing Market by Country, 2015 - 2018, USD Million
TABLE 220 Asia Pacific Sequencing Market by Country, 2019 - 2025, USD Million
TABLE 221 Asia Pacific Polymerase Chain Reaction Market by Country, 2015 - 2018, USD Million
TABLE 222 Asia Pacific Polymerase Chain Reaction Market by Country, 2019 - 2025, USD Million
TABLE 223 Asia Pacific Electrophoresis Market by Country, 2015 - 2018, USD Million
TABLE 224 Asia Pacific Electrophoresis Market by Country, 2019 - 2025, USD Million
TABLE 225 Asia Pacific Mass Spectrometry Market by Country, 2015 - 2018, USD Million
TABLE 226 Asia Pacific Mass Spectrometry Market by Country, 2019 - 2025, USD Million
TABLE 227 Asia Pacific Microarray Market by Country, 2015 - 2018, USD Million
TABLE 228 Asia Pacific Microarray Market by Country, 2019 - 2025, USD Million
TABLE 229 Asia Pacific Others Market by Country, 2015 - 2018, USD Million
TABLE 230 Asia Pacific Others Market by Country, 2019 - 2025, USD Million
TABLE 231 Asia Pacific Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 232 Asia Pacific Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 233 Asia Pacific Oncology Market by Country, 2015 - 2018, USD Million
TABLE 234 Asia Pacific Oncology Market by Country, 2019 - 2025, USD Million
TABLE 235 Asia Pacific Psychiatry Market by Country, 2015 - 2018, USD Million
TABLE 236 Asia Pacific Psychiatry Market by Country, 2019 - 2025, USD Million
TABLE 237 Asia Pacific Infectious Diseases Market by Country, 2015 - 2018, USD Million
TABLE 238 Asia Pacific Infectious Diseases Market by Country, 2019 - 2025, USD Million
TABLE 239 Asia Pacific Neurological Diseases Market by Country, 2015 - 2018, USD Million
TABLE 240 Asia Pacific Neurological Diseases Market by Country, 2019 - 2025, USD Million
TABLE 241 Asia Pacific Pain Management Market by Country, 2015 - 2018, USD Million
TABLE 242 Asia Pacific Pain Management Market by Country, 2019 - 2025, USD Million
TABLE 243 Asia Pacific Cardiovascular Diseases Market by Country, 2015 - 2018, USD Million
TABLE 244 Asia Pacific Cardiovascular Diseases Market by Country, 2019 - 2025, USD Million
TABLE 245 Asia Pacific Others Market by Country, 2015 - 2018, USD Million
TABLE 246 Asia Pacific Others Market by Country, 2019 - 2025, USD Million
TABLE 247 Asia Pacific Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 248 Asia Pacific Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 249 Asia Pacific Hospitals and Clinics Market by Country, 2015 - 2018, USD Million
TABLE 250 Asia Pacific Hospitals and Clinics Market by Country, 2019 - 2025, USD Million
TABLE 251 Asia Pacific Research Institutions Market by Country, 2015 - 2018, USD Million
TABLE 252 Asia Pacific Research Institutions Market by Country, 2019 - 2025, USD Million
TABLE 253 Asia Pacific Academic Institutes Market by Country, 2015 - 2018, USD Million
TABLE 254 Asia Pacific Academic Institutes Market by Country, 2019 - 2025, USD Million
TABLE 255 Asia Pacific Pharmacogenomics Market by Country, 2015 - 2018, USD Million
TABLE 256 Asia Pacific Pharmacogenomics Market by Country, 2019 - 2025, USD Million
TABLE 257 China Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 258 China Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 259 China Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 260 China Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 261 China Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 262 China Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 263 China Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 264 China Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 265 Japan Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 266 Japan Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 267 Japan Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 268 Japan Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 269 Japan Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 270 Japan Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 271 Japan Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 272 Japan Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 273 India Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 274 India Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 275 India Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 276 India Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 277 India Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 278 India Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 279 India Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 280 India Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 281 South Korea Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 282 South Korea Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 283 South Korea Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 284 South Korea Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 285 South Korea Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 286 South Korea Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 287 South Korea Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 288 South Korea Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 289 Singapore Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 290 Singapore Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 291 Singapore Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 292 Singapore Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 293 Singapore Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 294 Singapore Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 295 Singapore Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 296 Singapore Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 297 Malaysia Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 298 Malaysia Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 299 Malaysia Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 300 Malaysia Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 301 Malaysia Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 302 Malaysia Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 303 Malaysia Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 304 Malaysia Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 305 Rest of Asia Pacific Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 306 Rest of Asia Pacific Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 307 Rest of Asia Pacific Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 308 Rest of Asia Pacific Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 309 Rest of Asia Pacific Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 310 Rest of Asia Pacific Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 311 Rest of Asia Pacific Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 312 Rest of Asia Pacific Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 313 LAMEA Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 314 LAMEA Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 315 LAMEA Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 316 LAMEA Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 317 LAMEA Sequencing Market by Country, 2015 - 2018, USD Million
TABLE 318 LAMEA Sequencing Market by Country, 2019 - 2025, USD Million
TABLE 319 LAMEA Polymerase Chain Reaction Market by Country, 2015 - 2018, USD Million
TABLE 320 LAMEA Polymerase Chain Reaction Market by Country, 2019 - 2025, USD Million
TABLE 321 LAMEA Electrophoresis Market by Country, 2015 - 2018, USD Million
TABLE 322 LAMEA Electrophoresis Market by Country, 2019 - 2025, USD Million
TABLE 323 LAMEA Mass Spectrometry Market by Country, 2015 - 2018, USD Million
TABLE 324 LAMEA Mass Spectrometry Market by Country, 2019 - 2025, USD Million
TABLE 325 LAMEA Microarray Market by Country, 2015 - 2018, USD Million
TABLE 326 LAMEA Microarray Market by Country, 2019 - 2025, USD Million
TABLE 327 LAMEA Others Market by Country, 2015 - 2018, USD Million
TABLE 328 LAMEA Others Market by Country, 2019 - 2025, USD Million
TABLE 329 LAMEA Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 330 LAMEA Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 331 LAMEA Oncology Market by Country, 2015 - 2018, USD Million
TABLE 332 LAMEA Oncology Market by Country, 2019 - 2025, USD Million
TABLE 333 LAMEA Psychiatry Market by Country, 2015 - 2018, USD Million
TABLE 334 LAMEA Psychiatry Market by Country, 2019 - 2025, USD Million
TABLE 335 LAMEA Infectious Diseases Market by Country, 2015 - 2018, USD Million
TABLE 336 LAMEA Infectious Diseases Market by Country, 2019 - 2025, USD Million
TABLE 337 LAMEA Neurological Diseases Market by Country, 2015 - 2018, USD Million
TABLE 338 LAMEA Neurological Diseases Market by Country, 2019 - 2025, USD Million
TABLE 339 LAMEA Pain Management Market by Country, 2015 - 2018, USD Million
TABLE 340 LAMEA Pain Management Market by Country, 2019 - 2025, USD Million
TABLE 341 LAMEA Cardiovascular Diseases Market by Country, 2015 - 2018, USD Million
TABLE 342 LAMEA Cardiovascular Diseases Market by Country, 2019 - 2025, USD Million
TABLE 343 LAMEA Others Market by Country, 2015 - 2018, USD Million
TABLE 344 LAMEA Others Market by Country, 2019 - 2025, USD Million
TABLE 345 LAMEA Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 346 LAMEA Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 347 LAMEA Hospitals and Clinics Market by Country, 2015 - 2018, USD Million
TABLE 348 LAMEA Hospitals and Clinics Market by Country, 2019 - 2025, USD Million
TABLE 349 LAMEA Research Institutions Market by Country, 2015 - 2018, USD Million
TABLE 350 LAMEA Research Institutions Market by Country, 2019 - 2025, USD Million
TABLE 351 LAMEA Academic Institutes Market by Country, 2015 - 2018, USD Million
TABLE 352 LAMEA Academic Institutes Market by Country, 2019 - 2025, USD Million
TABLE 353 LAMEA Pharmacogenomics Market by Country, 2015 - 2018, USD Million
TABLE 354 LAMEA Pharmacogenomics Market by Country, 2019 - 2025, USD Million
TABLE 355 Brazil Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 356 Brazil Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 357 Brazil Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 358 Brazil Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 359 Brazil Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 360 Brazil Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 361 Brazil Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 362 Brazil Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 363 Argentina Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 364 Argentina Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 365 Argentina Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 366 Argentina Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 367 Argentina Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 368 Argentina Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 369 Argentina Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 370 Argentina Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 371 UAE Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 372 UAE Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 373 UAE Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 374 UAE Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 375 UAE Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 376 UAE Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 377 UAE Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 378 UAE Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 379 Saudi Arabia Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 380 Saudi Arabia Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 381 Saudi Arabia Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 382 Saudi Arabia Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 383 Saudi Arabia Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 384 Saudi Arabia Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 385 Saudi Arabia Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 386 Saudi Arabia Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 387 South Africa Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 388 South Africa Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 389 South Africa Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 390 South Africa Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 391 South Africa Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 392 South Africa Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 393 South Africa Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 394 South Africa Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 395 Nigeria Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 396 Nigeria Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 397 Nigeria Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 398 Nigeria Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 399 Nigeria Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 400 Nigeria Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 401 Nigeria Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 402 Nigeria Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 403 Rest of LAMEA Pharmacogenomics Market, 2015 - 2018, USD Million
TABLE 404 Rest of LAMEA Pharmacogenomics Market, 2019 - 2025, USD Million
TABLE 405 Rest of LAMEA Pharmacogenomics Market by Technology, 2015 - 2018, USD Million
TABLE 406 Rest of LAMEA Pharmacogenomics Market by Technology, 2019 - 2025, USD Million
TABLE 407 Rest of LAMEA Pharmacogenomics Market by Application, 2015 - 2018, USD Million
TABLE 408 Rest of LAMEA Pharmacogenomics Market by Application, 2019 - 2025, USD Million
TABLE 409 Rest of LAMEA Pharmacogenomics Market by End User, 2015 - 2018, USD Million
TABLE 410 Rest of LAMEA Pharmacogenomics Market by End User, 2019 - 2025, USD Million
TABLE 411 Key Information – ABBOTT Laboratories
TABLE 412 key information - empire genomics llc
TABLE 413 Key information – illumina, inc.
TABLE 414 Key Information – oneome llc
TABLE 415 Key Information – myriad genetics inc.
TABLE 416 Key Information – Thermo Fisher Scientific, Inc.
TABLE 417 Key information – teva pharmaceuticals industries ltd.
TABLE 418 Key Information – Bayer AG
TABLE 419 Key Information – opko health, inc.
TABLE 420 Key information – BECTON, DICKINSON AND COmpany

 List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: Abbott laboratories
FIG 3 Swot analysis: thermo fisher scientific, inc.
FIG 4 Swot analysis: bayer ag
FIG 5 Swot analysis: Becton, Dickinson and company